Hypertension Research Today is a free monthly online journal that collates and summarizes the latest research about Hypertension, including details on symptoms, diagnosis, diet, treatment, causes.

Volume 1 (2004), Issue 2 (October)

1. Plasma B-type natriuretic peptide reflects left ventricular hypertrophy and diastolic function in hypertension.
   Int J Cardiol, 97(2): 251-6. [Abstract] [Full-text]
2. eNOS Glu298Asp polymorphism and hypertension in a cohort study in Japanese.
   Prev Med, 39(5): 927-31. [Abstract] [Full-text]
3. Decreased cardiac mitochondrial NADP+-isocitrate dehydrogenase activity and expression: a marker of oxidative stress in hypertrophy development.
   Am J Physiol Heart Circ Physiol, 287(5): H2122-31. [Abstract] [Full-text]
4. Differential traffic of proximal tubule Na+ transporters during hypertension or PTH: NHE3 to base of microvilli vs. NaPi2 to endosomes.
   Am J Physiol Renal Physiol, 287(5): F896-906. [Abstract] [Full-text]
5. Doxycycline inducible expression of SERCA2a improves calcium handling and reverts cardiac dysfunction in pressure overload-induced cardiac hypertrophy.
   Am J Physiol Heart Circ Physiol, 287(5): H2164-72. [Abstract] [Full-text]
6. Glucocorticoid exposure in late gestation in the rat permanently programs gender-specific differences in adult cardiovascular and metabolic physiology.
   Am J Physiol Endocrinol Metab, 287(5): E863-70. [Abstract] [Full-text]
7. Insulin infusion induces endothelin-1-dependent hypertension in rats.
   Am J Physiol Endocrinol Metab, 287(5): E948-54. [Abstract] [Full-text]
8. Quercetin prevents oxidative stress and NF-kappaB activation in gastric mucosa of portal hypertensive rats.
   Biochem Pharmacol, 68(10): 1939-46. [Abstract] [Full-text]
9. Haplotypic analyses of the aldosterone synthase gene CYP11B2 associated with stage-2 hypertension in northern Han Chinese.
   Clin Genet, 66(5): 409-16. [Abstract] [Full-text]
10. Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE Study.
    Kidney Int Suppl. [Abstract] [Full-text]
11. Predictors of cardiovascular events in patients with type 2 diabetic nephropathy and hypertension: a case for albuminuria.
    Kidney Int Suppl. [Abstract] [Full-text]
12. Effect of proteinuria and glomerular filtration rate on cardiovascular risk in essential hypertension.
    Kidney Int Suppl. [Abstract] [Full-text]
13. Albuminuria: marker or target in indigenous populations.
    Kidney Int Suppl. [Abstract] [Full-text]
14. Prevalence of albuminuria in Australia: the AusDiab Kidney Study.
    Kidney Int Suppl. [Abstract] [Full-text]
15. Inclusion of albuminuria in hypertension and heart guidelines.
    Kidney Int Suppl. [Abstract] [Full-text]
16. Health economics studies assessing irbesartan use in patients with hypertension, type 2 diabetes, and microalbuminuria.
    Kidney Int Suppl. [Abstract] [Full-text]
17. Proteinuria and hypertensive nephrosclerosis in African Americans.
    Kidney Int Suppl. [Abstract] [Full-text]
18. A comparison of left ventricular mass between two-dimensional echocardiography, using fundamental and tissue harmonic imaging, and cardiac MRI in patients with hypertension.
    Eur J Radiol, 52(2): 103-9. [Abstract] [Full-text]
19. Angiotensin II type 1 receptor blockers reduce tissue factor activity and plasminogen activator inhibitor type-1 antigen in hypertensive patients: a randomized, double-blind, placebo-controlled study.
    Atherosclerosis, 177(1): 155-60. [Abstract] [Full-text]
20. Progesterone abolishes estrogen and/or atorvastatin endothelium dependent vasodilatory effects.
    Atherosclerosis, 177(1): 89-96. [Abstract] [Full-text]
21. Effect of hormone therapy on BP in normotensive and hypertensive postmenopausal women.
    Maturitas, 49(3): 189-203. [Abstract] [Full-text]
22. Prenatal exposure to interleukin-6 results in hypertension and increased hypothalamic-pituitary-adrenal axis activity in adult rats.
    Endocrinology, 145(11): 4897-911. [Abstract] [Full-text]
23. Hypertensive disorders of pregnancy.
    Int J Gynaecol Obstet, 87(2): 194-8. [Abstract] [Full-text]
24. Naturally occurring intrauterine growth retardation and adult blood pressure in rats.
    Pediatr Res, 56(5): 763-7. [Abstract] [Full-text]
25. Endothelium and angiogenesis in white coat hypertension.
    J Hum Hypertens, 18(11): 809-14. [Abstract] [Full-text]
26. Evidence for affluence-related hypertension in urban Brazil.
    J Hum Hypertens, 18(11): 775-9. [Abstract] [Full-text]
27. The microsatellite alleles on chromosome 1 associated with essential hypertension and blood pressure levels.
    J Hum Hypertens, 18(11): 823-8. [Abstract] [Full-text]
28. Effect of ingesting sour milk fermented using Lactobacillus helveticus bacteria producing tripeptides on blood pressure in subjects with mild hypertension.
    J Hum Hypertens, 18(11): 795-802. [Abstract] [Full-text]
29. Influence of the presence of doctors-in-training on the blood pressure of patients: a randomised controlled trial in 22 teaching practices.
    J Hum Hypertens, 18(11): 769-73. [Abstract] [Full-text]
30. Gamma-glutamyltransferase: an effect modifier in the association between age and hypertension in a 4-year follow-up study.
    J Hum Hypertens, 18(11): 803-7. [Abstract] [Full-text]
31. Estimated phytochemical content of the dietary approaches to stop hypertension (DASH) diet is higher than in the Control Study Diet.
    J Am Diet Assoc, 104(11): 1725-7. [Abstract] [Full-text]
32. Hypertension in diabetes: is there a place for age-adjusted centile cut-offs in those aged <50 years?
    QJM, 97(11): 747-53. [Abstract] [Full-text]
33. Diurnal blood glucose profiles in women with gestational diabetes with or without hypertension.
    Diabet Med, 21(11): 1181-4. [Abstract] [Full-text]
34. The biochemical response of the heart to hypertension and exercise.
    Trends Biochem Sci, 29(11): 609-17. [Abstract] [Full-text]
35. Role of exercise training on cardiovascular disease in persons who have type 2 diabetes and hypertension.
    Cardiol Clin, 22(4): 569-86. [Abstract] [Full-text]
36. Diabetes in the elderly and in women: cardiovascular risks.
    Cardiol Clin, 22(4): 541-51, vi. [Abstract] [Full-text]
37. The relationship between hyperinsulinemia, hypertension and progressive renal disease.
    J Am Soc Nephrol, 15(11): 2816-27. [Abstract] [Full-text]
38. Gender-specific influence of NO synthase gene on blood pressure since childhood: the Bogalusa Heart Study.
    Hypertension, 44(5): 668-73. [Abstract] [Full-text]
39. The association between blood pressure, hypertension, and cerebral white matter lesions: cardiovascular determinants of dementia study.
    Hypertension, 44(5): 625-30. [Abstract] [Full-text]
40. Blood pressure-related cognitive decline: does age make a difference?
    Hypertension, 44(5): 631-6. [Abstract] [Full-text]
41. Impairment of the low-affinity state beta1-adrenoceptor-induced relaxation in spontaneously hypertensive rats.
    Br J Pharmacol, 143(5): 599-605. [Abstract] [Full-text]
42. Interaction between an 11betaHSD1 gene variant and birth era modifies the risk of hypertension in Pima Indians.
    Hypertension, 44(5): 681-8. [Abstract] [Full-text]
43. Primed polymorphonuclear leukocytes, oxidative stress, and inflammation antecede hypertension in the Sabra rat.
    Hypertension, 44(5): 764-9. [Abstract] [Full-text]
44. Mapping the genetic determinants of hypertension, metabolic diseases, and related phenotypes in the lyon hypertensive rat.
    Hypertension, 44(5): 695-701. [Abstract] [Full-text]
45. Association between factor VII polymorphisms and blood pressure: the Stanislas Cohort.
    Hypertension, 44(5): 674-80. [Abstract] [Full-text]
46. Pathophysiology of hypertensive renal damage: implications for therapy.
    Hypertension, 44(5): 595-601. [Abstract] [Full-text]
47. Measuring adherence to practice guidelines for the management of hypertension: an evaluation of the literature.
    Hypertension, 44(5): 602-8. [Abstract] [Full-text]
48. Clinical outcomes in the diabetes cohort of the INternational VErapamil SR-Trandolapril study.
    Hypertension, 44(5): 637-42. [Abstract] [Full-text]
49. Angiotensin-(1-7) inhibitory mechanism of norepinephrine release in hypertensive rats.
    Hypertension, 44(5): 783-7. [Abstract] [Full-text]
50. Epistatic interaction between beta2-adrenergic receptor and neuropeptide Y genes influences LDL-cholesterol in hypertension.
    Hypertension, 44(5): 689-94. [Abstract] [Full-text]

© 2004-2008 Hypertension Research Today. All Rights Reserved.